Investors Asset Management of Georgia’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.26M | Sell |
93,803
-747
| -0.8% | -$19.5K | 0.79% | 37 |
|
|
2026
Q1 | $2.65M | Buy |
94,550
+3,023
| +3% | +$80.5K | 1.09% | 19 |
|
|
2025
Q4 | $2.28M | Sell |
91,527
-3,161
| -3% | -$79.7K | 0.94% | 27 |
|
|
2025
Q3 | $2.41M | Sell |
94,688
-584
| -0.6% | -$14.4K | 1.03% | 21 |
|
|
2025
Q2 | $2.31M | Buy |
95,272
+664
| +0.7% | +$15.5K | 1.07% | 23 |
|
|
2025
Q1 | $2.4M | Sell |
94,608
-1,577
| -2% | -$41.3K | 1.21% | 18 |
|
|
2024
Q4 | $2.55M | Buy |
96,185
+8,339
| +9% | +$226K | 1.24% | 17 |
|
|
2024
Q3 | $2.54M | Buy |
87,846
+8,111
| +10% | +$237K | 1.2% | 17 |
|
|
2024
Q2 | $2.23M | Buy |
79,735
+8,220
| +11% | +$226K | 1.09% | 19 |
|
|
2024
Q1 | $1.98M | Buy |
71,515
+6,625
| +10% | +$184K | 0.93% | 26 |
|
|
2023
Q4 | $1.88M | Buy |
64,890
+1,217
| +2% | +$36.8K | 0.95% | 23 |
|
|
2023
Q3 | $2.13M | Buy |
63,673
+905
| +1% | +$32K | 1.18% | 18 |
|
|
2023
Q2 | $2.3M | Buy |
62,768
+2,280
| +4% | +$88.7K | 1.19% | 16 |
|
|
2023
Q1 | $2.47M | Sell |
60,488
-1,645
| -3% | -$71K | 1.32% | 15 |
|
|
2022
Q4 | $3.18M | Buy |
62,133
+64
| +0.1% | +$3.07K | 1.66% | 12 |
|
|
2022
Q3 | $2.72M | Sell |
62,069
-122
| -0.2% | -$5.93K | 1.4% | 13 |
|
|
2022
Q2 | $3.26M | Sell |
62,191
-274
| -0.4% | -$14K | 1.69% | 11 |
|
|
2022
Q1 | $3.23M | Buy |
62,465
+931
| +2% | +$48.3K | 1.63% | 10 |
|
|
2021
Q4 | $3.63M | Buy |
61,534
+102
| +0.2% | +$5.05K | 1.73% | 9 |
|
|
2021
Q3 | $2.64M | Buy |
61,432
+2,293
| +4% | +$102K | 1.37% | 11 |
|
|
2021
Q2 | $2.32M | Buy |
59,139
+590
| +1% | +$22.9K | 1.25% | 13 |
|
|
2021
Q1 | $2.12M | Buy |
58,549
+4,325
| +8% | +$154K | 1.23% | 12 |
|
|
2020
Q4 | $2M | Sell |
54,224
-4,140
| -7% | -$152K | 1.35% | 12 |
|
|
2020
Q3 | $2.03M | Buy |
58,364
+843
| +1% | +$29.6K | 1.36% | 10 |
|
|
2020
Q2 | $1.78M | Sell |
57,521
-543
| -0.9% | -$18.4K | 1.24% | 11 |
|
|
2020
Q1 | $1.8M | Buy |
58,064
+1,012
| +2% | +$34.5K | 1.47% | 9 |
|
|
2019
Q4 | $2.12M | Buy |
57,052
+264
| +0.5% | +$9.4K | 1.29% | 13 |
|
|
2019
Q3 | $1.94M | Buy |
56,788
+492
| +0.9% | +$17.9K | 1.23% | 12 |
|
|
2019
Q2 | $2.31M | Buy |
56,296
+456
| +0.8% | +$18.1K | 1.56% | 10 |
|
|
2019
Q1 | $2.25M | Sell |
55,840
-221
| -0.4% | -$8.85K | 1.57% | 9 |
|
|
2018
Q4 | $2.32M | Buy |
56,061
+211
| +0.4% | +$8.76K | 1.9% | 8 |
|
|
2018
Q3 | $2.33M | Sell |
55,850
-949
| -2% | -$36.5K | 1.63% | 9 |
|
|
2018
Q2 | $1.96M | Buy |
56,799
+181
| +0.3% | +$6.18K | 1.43% | 12 |
|
|
2018
Q1 | $1.91M | Buy |
56,618
+627
| +1% | +$21.6K | 1.41% | 13 |
|
|
2017
Q4 | $1.92M | Sell |
55,991
-1,053
| -2% | -$35.9K | 1.37% | 13 |
|
|
2017
Q3 | $1.93M | Buy |
57,044
+317
| +0.6% | +$10.2K | 1.42% | 14 |
|
|
2017
Q2 | $1.81M | Sell |
56,727
-13
| -0% | -$410 | 1.24% | 13 |
|
|
2017
Q1 | $1.84M | Buy |
56,740
+933
| +2% | +$29.4K | 1.28% | 11 |
|
|
2016
Q4 | $1.72M | Buy |
55,807
+2,361
| +4% | +$72.1K | 1.27% | 13 |
|
|
2016
Q3 | $1.72M | Sell |
53,446
-727
| -1% | -$24.3K | 1.3% | 14 |
|
|
2016
Q2 | $1.81M | Sell |
54,173
-1,002
| -2% | -$32K | 1.41% | 11 |
|
|
2016
Q1 | $1.55M | Buy |
55,175
+206
| +0.4% | +$5.88K | 1.29% | 13 |
|
|
2015
Q4 | $1.68M | Buy |
54,969
+827
| +2% | +$26K | 1.41% | 12 |
|
|
2015
Q3 | $1.61M | Sell |
54,142
-169
| -0.3% | -$5.42K | 1.45% | 12 |
|
|
2015
Q2 | $1.73M | Buy |
54,311
+211
| +0.4% | +$6.88K | 1.48% | 11 |
|
|
2015
Q1 | $1.79M | Sell |
54,100
-316
| -0.6% | -$10K | 1.47% | 10 |
|
|
2014
Q4 | $1.61M | Buy |
+54,416
| New | +$1.56M | 1.39% | 11 |
|
Other funds holding PFE
Investors Asset Management of Georgia's PFE Position: Q2 2026 in Review
Investors Asset Management of Georgia reduced its Pfizer (PFE) stake by 0.79% in Q2 2026, selling an estimated $19.5K and leaving 93,803 shares worth $2.26M. The position accounts for 0.79% of the portfolio, ranked #37.
Investors Asset Management of Georgia first reported a position in PFE in Q4 2014 and has held it in 47 quarters since. The position peaked at $3.63M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Investors Asset Management of Georgia held 93,803 shares of Pfizer worth $2.26M as of Q2 2026.
- Investors Asset Management of Georgia sold 747 Pfizer shares in Q2 2026, an estimated $19.5K.
- Pfizer made up 0.79% of Investors Asset Management of Georgia's portfolio in Q2 2026, its #37 holding.
- Investors Asset Management of Georgia first reported a position in Pfizer in Q4 2014 and has held it in 47 quarters since.
- Investors Asset Management of Georgia's Pfizer position peaked at $3.63M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Investors Asset Management of Georgia's 13F filing for Q2 2026, filed 22 Jul 2026.